荔枝视频

A generous gift. A bold idea. And a top-ranking grant. That鈥檚 the trajectory of a 荔枝视频 research project that鈥檚 helping us understand the heart鈥檚 potential to heal.

In 2023, a team of multidisciplinary researchers at the Libin Cardiovascular Institute received inaugural support from the Michael and Terry Wilson Cardiovascular Research Innovation Fund. Their mission was to investigate the role of epicardial adipose tissue (EAT)鈥攖he fatty tissue that surrounds the heart鈥攊n driving or protecting against cardiovascular disease.

Now, some members of that team have leveraged early-stage philanthropic support into more success. Researchers Dr. Vaibhav Patel, PhD, and Dr. Paul Fedak, MD, PhD, secured a highly competitive Canadian Institutes of Health Research (CIHR) Project Grant, ranking first in the pan-Canadian competition.

鈥淚t鈥檚 a powerful example of how philanthropy accelerates science,鈥� says Fedak, Libin Institute director. 鈥淭he Wilson funding allowed us to generate the critical early data we needed to show the potential of this new area of research. We鈥檙e now building on that foundation to explore therapies that could truly change lives.鈥�

A novel frontier in heart health

While cardiovascular disease remains the leading cause of premature death worldwide, EAT has emerged as a potential key player. This fat tissue, once thought to be biologically inert, is now being recognized for its active role in inflammation, scarring and cellular signaling that may influence heart and vascular conditions like atrial fibrillation and post-heart attack healing.

With the Wilson funding, Patel and a diverse team of scientists and clinicians began deciphering the molecular crosstalk between EAT and the heart鈥攈ow signals from this tissue might spark or suppress disease processes. That research opened the door to a new and intriguing hypothesis: that stem cells found within EAT could help the heart heal after a heart attack.

Unlocking the heart鈥檚 healing potential

Backed by the CIHR grant, Patel and Fedak are now looking deeper to understand the mechanisms behind how EAT-derived stem cells might stimulate the repair of damaged heart tissue. Exciting early data from Patel鈥檚 lab suggests these stem cells do have cardioprotective properties鈥攂ut that function is impaired in people with Type 2 diabetes, a group at especially high risk for heart complications.

鈥淲e are looking at finding the magic factor that鈥檚 cardioprotective,鈥� says Patel. 鈥淚f we can understand what factors are driving or stopping this healing response, we can use that information to develop personalized therapies to improve outcomes after heart attacks.鈥�

Samples from local cardiac surgery patients, collected as part of Fedak鈥檚 translational research program, are being used in conjunction with animal models to test these theories. It鈥檚 an approach made possible through strong collaboration.

From seed to success

For both Patel and Fedak, this work underscores the immense value of early-stage, donor-driven funding in catalyzing discovery. The Michael and Terry Wilson Cardiovascular Research Innovation Fund was specifically created to support high-risk, high-reward ideas鈥攑rojects that may not yet be ready for large-scale grant competitions but hold extraordinary potential.

鈥淭he Michael and Terry Wilson gift came at the right time,鈥� says Fedak. 鈥淲ithout it, we wouldn鈥檛 have been able to generate the preliminary data that helped us secure the CIHR funding. That support was critical.鈥�

As this groundbreaking research continues, the Libin Cardiovascular Institute remains committed to fostering innovation that can improve heart health in 荔枝视频 and beyond. And behind many of these innovations are visionary donors who believe in the science鈥攁nd the people鈥攚orking to push it forward.

鈥淲e鈥檙e incredibly grateful,鈥� says Patel. 

Learn how you too can support the Libin Cardiovascular Institute .